The London Borough of Sutton has purchased a further 0.38 hectares of NHS land on the site of The London Cancer Hub – a partnership with The Institute of Cancer Research, London, and one of the UK’s most significant regeneration projects.
Finalising the land deal has opened the way for the London Borough of Sutton to seek a development partner for a £350 million life science campus, bringing forward new buildings on the site.
The London Borough of Sutton invested £2.199 million in the final portion of land on the site, taking the total to £30.299 million.
Development on the site in Sutton, south London, will now accelerate as the partners aim to deliver on their goal of creating the world’s leading hub for cancer research, education and enterprise.
The London Cancer Hub aims to be a global centre for cancer innovation, bringing together scientists, doctors, a variety of life science companies, patients and the local community.
It is led by the London Borough of Sutton and The Institute of Cancer Research (ICR), with the support of The Royal Marsden NHS Foundation Trust and The Mayor of London.
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:
“There has been an explosion in our knowledge of cancer over the last decade, and we’re seeing the fruits of that understanding in a succession of exciting new treatments for the disease.
“But there is still much more to do to translate research advances into innovative cancer treatments – and part of the answer is to stimulate intensive collaboration between academia and industry.
“I’m incredibly excited by the potential of The London Cancer Hub to spark creativity, innovation and collaboration, and to take many more exciting new cancer treatments through to patients.
“This is one of the most ambitious life science projects in the world – and we’re proud to be working with the London Borough of Sutton in making it a reality. It’s great to have reached such a significant milestone, and I’m now looking forward to bringing in a commercial development partner that shares our ambition to create a truly world-leading research and enterprise hub.”
